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Summary
Background Lifestyle factors influence the risk of morbidity and mortality, but the extent to which they are associated 
with employees’ absence from work due to illness is unclear. We examined the relative contributions of smoking, 
alcohol consumption, high body-mass index, and low physical activity to diagnosis-specific sickness absence.
Methods We did a multicohort study with individual-level data of participants of four cohorts from the UK, France, 
and Finland. Participants’ responses to a lifestyle survey were linked to records of sickness absence episodes, typically 
lasting longer than 9 days; for each diagnostic category, the outcome was the total number of sickness absence days 
per year. We estimated the associations between lifestyle factors and sickness absence by calculating rate ratios for the 
number of sickness absence days per year and combining cohort-specific estimates with meta-analysis. The criteria 
for assessing the evidence included the strength of association, consistency across cohorts, robustness to adjustments 
and multiple testing, and impact assessment by use of population attributable fractions (PAF), with both internal 
lifestyle factor prevalence estimates and those obtained from European populations (PAFexternal).
Findings For 74 296 participants, during 446 478 person-years at risk, the most common diagnoses for sickness 
absence were musculoskeletal diseases (70·9 days per 10 person-years), depressive disorders (26·5 days per 10 person-
years), and external causes (such as injuries and poisonings; 12·8 days per 10 person-years). Being overweight (rate 
ratio [adjusted for age, sex, socioeconomic status, and chronic disease at baseline] 1·30, 95% CI 1·21–1·40; PAFexternal 
8·9%) and low physical activity (1·23, 1·14–1·34; 7·8%) were associated with absences due to musculoskeletal 
diseases; heavy episodic drinking (1·90, 1·41–2·56; 15·2%), smoking (1·70, 1·42–2·03; 11·8%), low physical activity 
(1·67, 1·42–1·96; 19·8%), and obesity (1·38, 1·11–1·71; 5·6%) were associated with absences due to depressive 
disorders; heavy episodic drinking (1·64, 1·33–2·03; 11·3%), obesity (1·48, 1·27–1·72; 6·6%), smoking (1·35, 
1·20–1·53; 6·3%), and being overweight (1·20, 1·08–1·33; 6·2%) were associated with absences due to external 
causes; obesity (1·82, 1·40–2·36; 11·0%) and smoking (1·60, 1·30–1·98; 10·3%) were associated with absences due 
to circulatory diseases; low physical activity (1·37, 1·25–1·49; 12·0%) and smoking (1·27, 1·16–1·40; 4·9%) were 
associated with absences due to respiratory diseases; and obesity (1·67, 1·34–2·07; 9·7%) was associated with 
absences due to digestive diseases.
Interpretation Lifestyle factors are associated with sickness absence due to several diseases, but observational data 
cannot determine the nature of these associations. Future studies should investigate the cost-effectiveness of lifestyle 
interventions aimed at reducing sickness absence and the use of information on lifestyle for identifying groups at risk.
Funding NordForsk, British Medical Research Council, Academy of Finland, Helsinki Institute of Life Sciences, and 
Economic and Social Research Council.
Copyright © The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license.
Introduction
The absence from work due to illness (ie, sickness 
absence) is a great concern in many countries, 
emphasising the importance of knowing the modifiable 
risk factor targets for disability prevention, maintaining 
an active work force, and extending working lives.1 Risk 
factors related to lifestyle, such as smoking, risky alcohol 
use, high body-mass index (BMI), and low physical 
activity, account for a substantial proportion of years of 
life lost due to disability and premature mortality.2 
However, the importance of lifestyle factors in terms of 
sickness absence in working populations has rarely been 
in focus.3–6
Available evidence on lifestyle and diagnosis-specific 
sickness absence is limited to investigations that have 
assessed one lifestyle factor or one diagnosis outcome at 
a time, thus preventing comparisons of the relative 
importance of different lifestyle factors for different 
diagnostic groups.7–19 Some of these studies have been 
small in scale (sample size between 200 and 
4000 participants) and have provided imprecise 
estimates.11–14,17 The overall evidence is characterised by 
mixed findings.7–19
In this study, we aim to quantify the associations 
between lifestyle factors (smoking, alcohol consumption, 
BMI, and physical activity) and sickness absence due 
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to six specific diagnoses: musculoskeletal diseases, 
depressive disorders, external causes (eg, injuries and 




We used individual-level data from four cohort studies: 
the Finnish Public Sector (FPS) study (Finland),20 which 
is an occupational cohort of public sector employees; the 
Health and Social Support (HeSSup) study (Finland),21 
which is a population-based cohort of working-age 
adults; the Whitehall II study (UK), 22 a cohort of London-
based civil servants; and the GAZEL study (France),23 a 
cohort of employees from the national gas and electricity 
company. All cohort studies were approved by local ethics 
committees: the Ethics Committee of the Hospital 
District of Helsinki and Uusimaa (Finland) approved 
FPS, the Turku University Central Hospital Ethics 
committee (Finland) approved HeSSup, the University 
College London Medical School committee on the ethics 
of human research (UK) approved Whitehall II, and the 
Inserm Ethics committee (France) approved GAZEL. All 
participants gave their informed consent.
We included respondents who were alive, responded to 
the baseline surveys, and were not retired from work 
before the start of follow-up of the respective studies. 
The FPS survey was done in 2004, HeSSup in 2003, 
GAZEL in 1997, and Whitehall II in 1991–94. Follow-up 
(time at risk) for all cohorts was until old-age pension, 
death, or end of follow-up period, whichever came first. 
Details of register follow-up are provided in the appendix 
(p 3). The mean follow-up was 6·5 (SD 1·4) years in FPS, 
6·7 (1·1) in HeSSup, 3·8 (2·3) in GAZEL, and 4·4 (2·1) 
in Whitehall II.
Procedures
Lifestyle factors were based on self-reported information, 
except for height and weight in one of the studies 
(Whitehall II). Smoking status included categories of 
current smoker and non-smoker. We defined high alcohol 
consumption as a weekly consumption exceeding 112 g of 
absolute alcohol for both men and women, according 
to 2016 guidelines in the UK.24 Moderate alcohol con-
sumption referred to a weekly consumption of more than 
0 g and 112 g or fewer. Heavy episodic drinking was 
defined as a participant reporting having passed out at 
least once because of heavy drinking during the past 
12 months (data available in FPS and HeSSup). BMI was 
categorised as lower than 18·5 kg/m² (underweight), 
18·5–24·9 kg/m² (normal weight), 25·0–29·9 kg/m² 
(overweight), and 30·0 kg/m² or higher (obesity). Leisure-
time physical activity was a dichotomous variable, 
including low physical activity versus intermediate and 
high physical activity. Details of lifestyle factors are 
provided in the appendix (p 2).
Sickness absence was measured as the number of 
diagnosis-specific sickness absence days per year derived 
Research in context
Evidence before this study
In addition to morbidity and mortality, lifestyle factors such as 
smoking, risky alcohol use, high body-mass index (BMI), and low 
physical activity might increase the risk of absence from work 
due to illness (ie, sickness absence). We searched PubMed for 
studies published before June 19, 2018, on lifestyle factors and 
sickness absence without language restrictions, by using the 
following search terms for titles and abstracts: ("physical" AND 
"activity" AND "sickness" AND "absence") OR ("overweight" AND 
"sickness" AND "absence") OR ("obesity" AND "sickness" AND 
"absence") OR ("smoking" AND "sickness" AND "absence") OR 
("alcohol" AND "sickness" AND "absence") OR ("health" AND 
"behaviours" AND "sickness" AND "absence") OR ("lifestyle" AND 
"sickness" AND "absence"). We found evidence for an association 
between lifestyle factors and all-cause sickness absence, but 
findings from the 13 studies on diagnosis-specific sickness 
absence were mixed. Previous studies typically focused on a single 
lifestyle factor and outcome, applied heterogeneous 
methodologies, and included small sample sizes.
Added value of this study
In addition to quantifying the magnitude of the association 
between lifestyle factors and risk of diagnosis-specific sickness 
absence in a large multicohort study, we assessed the quality of 
the evidence against the following criteria: strength of 
association, consistency across cohorts, robustness to 
adjustments and multiple testing, and public health impact of 
the observed associations, assessed by population attributable 
fractions. We determined a high or moderate rating for the 
association of high BMI and low physical activity with 
musculoskeletal diseases; for heavy episodic drinking, smoking, 
high BMI, and low physical activity in relation to depressive 
disorders; and for heavy episodic drinking, smoking, and high 
BMI in relation to external causes. We also determined a high or 
moderate rating for the association of smoking and obesity 
with sickness absence due to circulatory diseases and of 
smoking and low physical activity with sickness absence due to 
respiratory diseases.
Implications of all the available evidence
This multicohort study shows that lifestyle-related factors are 
likely to be important for work capacity among the 
working-age population. If the associations were causal, 
removal of the lifestyle risk factors would result in a substantial 
reduction in sickness absence. Future studies should investigate 
the cost-effectiveness of lifestyle interventions aimed at 
reducing sickness absence and the use of information on 
lifestyle factors for identifying groups at risk.
Correspondence to: 
Prof Marianna Virtanen, 
Department of Public Health and 
Caring Sciences, University of 
Uppsala, 752 37 Uppsala, Sweden 
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from health registers in all cohorts and summed up for 
the follow-up period, which was either until death, old-
age pension, or the end of follow-up of the respective 
studies. Details of sickness absences and covariates in 
each cohort are provided in the appendix (pp 3–5).
Statistical analysis
We examined the rate of diagnosis-specific sickness 
absence—the number of sickness absence days per year 
over the follow-up period—separately for six diagnoses: 
musculoskeletal diseases, depressive disorders, external 
causes (eg, injuries and poisonings), circulatory diseases, 
respiratory diseases, and digestive diseases. In the 
subgroup analyses of those who had at least 1 day of 
sickness absence, we examined the number of absence 
days per year recorded for these six conditions (indicating 
longer duration or repeated absences due to a diagnosis, 
eg, musculoskeletal disorder), and the number of 
absence days per year due to other causes (eg, absence 
days due to any of the other five conditions in addition to 
musculoskeletal disease).
We used a two-stage analysis. At the first stage, we 
analysed each cohort separately and used negative 
binomial regression analysis, which provides rate ratios 
and their 95% CIs for the number of sickness absence 
days and takes into account the length of follow-up (the 
offset variable in statistical models). Smokers were 
compared with non-smokers; participants with high 
alcohol consumption were compared with those with 
moderate alcohol consumption; participants in the 
overweight and obesity categories were each compared 
with those in the normal weight category; and participants 
with low physical activity were compared with those with 
high or moderate physical activity. The minimally 
adjusted models included age and sex as covariates. 
The multi variable models were also adjusted for 
socioeconomic status, chronic disease, and other lifestyle 
factors. In subgroup analyses, we stratified the analyses 
by prevalent chronic disease at baseline to assess whether 
the associations varied by chronic disease status. Study-
specific results were analysed with SAS 9.4 software.
At the second stage, we pooled study-specific rate ratio 
(RR) estimates in a fixed effects meta-analysis, which is 
suitable for studies with few cohorts,25 with Stata 15 
software. We examined heterogeneity in study-specific 
estimates with use of the I² test. We used Bonferroni 
correction to compensate for multiple testing (a total of 
36 tests from six lifestyle factor components and six 
sickness absence outcomes). We assessed the public 
health impact using population attributable fractions 
(PAF)—that is—the proportional reduction in diagnosis-
specific sickness absence that would occur if exposure to 
a risk factor was reduced to an alternative ideal exposure 
scenario (eg, from obesity to normal weight). 
To form a comprehensive summary of the findings, we 
assessed the evidence from the main analysis by rating 
the 36 observed estimates as high, moderate, or low or 
poor according to the following four criteria—strength of 
association: RR lower than 1·1 (low), 1·1–1·49 and 













Age, mean (SD) 45·5 (9·5) 41·8 (10·7) 51·0 (2·9) 48·7 (5·6)
Sex
Men 9231 (19·7) 4655 (38·6) 7645 (71·5) 3294 (71·9)
Women 37 743 (80·4) 7401 (61·4) 3041 (28·5) 1286 (28·1)
Socioeconomic status
Low 7098 (15·1) 4483 (37·2) 1147 (10·7) 729 (15·9)
Intermediate 12 990 (27·7) 3877 (32·2) 5559 (52·0) 2098 (45·8)
High 26 886 (57·2) 3696 (30·7) 3980 (37·2) 1753 (38·3)
Chronic disease
No 27 554 (58·7) 7720 (64·0) 8747 (81·9) 3120 (68·1)
Yes 19 420 (41·3) 4336 (36·0) 1939 (18·2) 1460 (31·9)
Smoking
No 37 870 (82·9) 9525 (79·8) 8622 (81·9) 3831 (85·4)
Yes 7834 (17·1) 2415 (20·2) 1900 (18·1) 654 (14·6)
Alcohol consumption
No 6545 (14·0) 1565 (13·0) 1241 (11·9) 857(18·7)
Within recommended limits 32 278 (69·1) 7724 (64·2) 5619 (54·0) 2556 (55·8)
High 7886 (16·9) 2740 (22·8) 3543 (34·1) 1165 (25·5)
Heavy episodic drinking*
No 43 283 (93·0) 10 598 (88·2) ·· ··
Yes 3234 (7·0) 1422 (11·8) ·· ··
Body-mass index
Underweight 480 (1·1) 143 (1·2) 99 (0·9) 43 (1·0)
Normal 24 196 (52·9) 6347 (53·0) 4997 (47·1) 2343 (52·4)
Overweight 15 182 (33·2) 4068 (34·0) 4554 (42·9) 1664 (37·2)
Obese 5911 (12·9) 1412 (11·8) 955 (9·0) 419 (9·4)
Low physical activity
No 37 565 (80·7) 9464 (78·9) 6266 (62·7) 3653 (79·8)
Yes 8984 (19·3) 2538 (21·2) 3727 (37·3) 926 (20·2)
Participants with ≥1 day of sickness absence at follow-up
Musculoskeletal diseases 12 911 (27·5) 2165 (18·0) 1850 (17·3) 926 (20·2)
Depressive disorders 3700 (7·9) 656 (5·4) 587 (5·5) 746 (16·3)
External causes 5649 (12·0) 1139 (9·4) 1548 (14·5) 829 (18·1)
Circulatory diseases 2490 (5·3) 440 (3·6) 628 (5·9) 113 (2·5)
Respiratory diseases 3198 (6·8) 525 (4·4) 2127 (19·9) 2838 (62·0)
Digestive diseases 2046 (4·4) 436 (3·6) 1135 (10·6) 617 (13·5)
Sickness absence days at follow-up, per 10 person-years
Musculoskeletal diseases 85·6 53·2 25·3 8·7
Depressive disorders 30·2 18·1 21·3 13·3
External causes 13·3 10·2 17·7 6·2
Circulatory diseases 10·4 8·1 13·2 3·1
Respiratory diseases 4·9 3·5 6·7 17·3
Digestive diseases 3·0 2·0 6·1 2·7
Data are n (%), unless specified otherwise. *Data available from Finnish Public Sector study20 and Health and Social 
Support study.21
Table 1: Characteristics of participants in four cohort studies
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consistency: I² values greater than 50% and significant 
(low), 25–50% (moderate), and lower than 25% (high); 
robustness to serial adjustments (plus exclusion of 
participants with a chronic disease) and multiple testing: 
RR not robust to adjustments (low), robust to adjustments, 
but not to multiple testing (moderate), and robust to 
adjustments and multiple testing (high); PAF: greater 
than 10% (high), 5–10% and significant (moderate), and 
lower than 5% (low). We considered strength of 
association by following Bradford Hill’s criteria.26 
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. MV, JP, and MKi had full access to 
all data. MV and MKi had final responsibility for the 
decision to submit for publication.
Results
The baseline characteristics of the 74 296 participants 
(24 825 men and 49 471 women) are shown in table 1. 
About half of participants were overweight or obese, one 
in three to one in five were physically inactive, consumed 
high levels of alcohol, or both, one in five or fewer were 
smokers, and one in ten reported heavy episodic drinking. 
During 446 478 person-years at risk (mean follow-up of 
6·0 years), the most common causes of sickness absence 
were musculoskeletal diseases, depressive disorders, 
external causes, and circulatory diseases.
Figure 1 shows summary estimates for the association 
between lifestyle factors and diagnosis-specific sickness 
absence (study-specific results are available in the 
appendix, pp 7–12). All lifestyle factors were associated 
with musculoskeletal diseases, with the exception of high 
alcohol consumption and heavy episodic drinking. Like-
wise, all lifestyle factors were associated with sickness 
absence due to depressive disorders (with the exception 
of being overweight), external causes (with the exception 
of low physical activity), and respiratory diseases (with the 
exception of being overweight). Obesity, smoking, and 
low physical activity were associated with sickness 
absence due to circulatory diseases. Obesity and low 
physical activity alone were significantly associated with 
sickness absence due to digestive diseases. Most of these 
associations were robust to multivariable adjustments, 
and there were few differences in the results of subgroup 
analyses among participants with and without chronic 
disease at baseline (table 2). The PAF for each lifestyle 
factor and the diagnosis-specific sickness absence out-
comes are shown in table 3.
By using the four criteria to assess and rate the overall 
evidence for each association between lifestyle factors 
and diagnosis-specific sickness absence (figure 2), we 
determined a high rating, with PAFs higher than 10%, 
for the associations of smoking, heavy episodic drinking, 
and low physical activity with absence due to depressive 
disorders; between heavy episodic drinking and absence 
due to external causes; between smoking and obesity, 
and absence due to circulatory diseases; and between low 
physical activity and absence due to respiratory diseases. 
We determined a moderate rating (PAFs ≤10%) for 
Figure 1: Rate ratio from meta-analyses for association between lifestyle factors and diagnosis-specific 
sickness absence, adjusted for age, sex, socioeconomic status and chronic disease
Error bars denote 95% CI.
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several other associations between lifestyle factors and 
diagnosis-specific sickness absences (figure 2).
Subgroup analyses included participants with 1 or 
more sickness absence days from each diagnostic group. 
The results are shown in the appendix (pp 13–14) and 
largely replicate those in the main analysis—in the 
assessment of both the number of sickness absence days 
within a single diagnosis and the number of sickness 
Age and sex adjusted 
(model 1)
Model 1 plus SES 
(model 2)
Model 2 plus adjustment 
for chronic disease and 
other lifestyle factors 
(model 3)
Model 2 excluding 
participants with a 
chronic disease (model 4)
Model 2 including only 
participants with a 
chronic disease (model 5)
Sickness absence due to musculoskeletal diseases
Smoking vs non-smoking 1·69 (1·54–1·85) 1·33 (1·21–1·45) 1·35 (1·23–1·48) 1·43 (1·26–1·63) 1·18 (1·04–1·34)
High vs moderate alcohol consumption 1·11 (1·02–1·22) 1·10 (1·01–1·21) 1·04 (0·95–1·14) 1·03 (0·91–1·17) 1·03 (0·90–1·18)
Heavy episodic drinking vs no episodic drinking 1·15 (1·00–1·33) 1·05 (0·91–1·21) 0·95 (0·82–1·09) 1·06 (0·86–1·31) 0·94 (0·78–1·13)
Overweight vs normal weight 1·46 (1·36–1·58) 1·37 (1·28–1·48) 1·37 (1·26–1·48) 1·29 (1·17–1·43) 1·31 (1·17–1·46)
Obesity vs normal weight 2·12 (1·90–2·37) 1·86 (1·67–2·07) 1·82 (1·62–2·03) 1·50 (1·27–1·77) 1·73 (1·50–1·98)
Low physical activity vs moderate and high activity 1·46 (1·34–1·59) 1·34 (1·23–1·45) 1·22 (1·12–1·34) 1·21 (1·07–1·36) 1·29 (1·16–1·44)
Sickness absence due to depressive disorders
Smoking vs non-smoking 1·93 (1·61–2·31) 1·95 (1·63–2·33) 1·93 (1·59–2·33) 1·76 (1·37–2·27) 1·63 (1·27–2·09)
High vs moderate alcohol consumption 1·27 (1·07–1·51) 1·30 (1·09–1·55) 1·06 (0·88–1·28) 1·37 (1·07–1·74) 1·09 (0·84–1·40)
Heavy episodic drinking vs no episodic drinking 1·85 (1·37–2·50) 1·77 (1·30–2·39) 1·79 (1·31–2·44) 2·28 (1·38–3·76) 1·38 (0·95–2·00)
Overweight vs normal weight 1·22 (1·05–1·41) 1·19 (1·03–1·38) 1·18 (1·01–1·37) 1·08 (0·87–1·33) 1·13 (0·91–1·40)
Obesity vs normal weight 1·61 (1·30–2·00) 1·63 (1·32–2·03) 1·62 (1·29–2·03) 1·51 (1·07–2·12) 1·26 (0·96–1·65)
Low physical activity vs moderate and high activity 1·78 (1·51–2·10) 1·73 (1·47–2·04) 1·52 (1·27–1·81) 1·63 (1·29–2·07) 1·57 (1·26–1·96)
Sickness absence due to external causes
Smoking vs non-smoking 1·53 (1·35–1·73) 1·35 (1·19–1·53) 1·34 (1·17–1·52) 1·40 (1·19–1·64) 1·26 (1·03–1·54)
High vs moderate alcohol consumption 1·18 (1·04–1·33) 1·22 (1·08–1·37) 1·19 (1·05–1·36) 1·19 (1·02–1·38) 1·20 (0·98–1·47)
Heavy episodic drinking vs no episodic drinking 1·75 (1·42–2·17) 1·68 (1·36–2·07) 1·60 (1·28–1·98) 1·61 (1·20–2·15) 1·65 (1·21–2·24)
Overweight vs normal weight 1·28 (1·15–1·42) 1·21 (1·09–1·34) 1·24 (1·11–1·38) 1·22 (1·07–1·39) 1·12 (0·94–1·33)
Obesity vs normal weight 1·70 (1·46–1·98) 1·57 (1·35–1·83) 1·57 (1·34–1·83) 1·54 (1·25–1·91) 1·34 (1·07–1·66)
Low physical activity vs moderate and high activity 1·04 (0·93–1·16) 0·98 (0·88–1·10) 0·86 (0·76–0·97) 0·91 (0·79–1·06) 0·93 (0·78–1·11)
Sickness absence due to circulatory diseases
Smoking vs non-smoking 1·70 (1·38–2·10) 1·59 (1·28–1·97) 1·64 (1·32–2·05) 1·71 (1·28–2·30) 1·55 (1·13–2·13)
High vs moderate alcohol consumption 0·94 (0·76–1·16) 0·91 (0·74–1·13) 0·87 (0·69–1·09) 0·82 (0·61–1·10) 1·00 (0·72–1·37)
Heavy episodic drinking vs no episodic drinking 1·27 (0·90–1·78) 1·27 (0·90–1·79) 1·18 (0·83–1·69) 1·13 (0·70–1·84) 1·23 (0·76–1·99)
Overweight vs normal weight 1·38 (1·15–1·64) 1·29 (1·08–1·55) 1·32 (1·10–1·59) 1·07 (0·84–1·37) 1·51 (1·14–1·99)
Obesity vs normal weight 2·24 (1·73–2·89) 2·11 (1·63–2·73) 2·05 (1·57–2·68) 1·94 (1·31–2·87) 2·06 (1·46–2·90)
Low physical activity vs moderate and high activity 1·46 (1·20–1·78) 1·37 (1·13–1·67) 1·22 (0·99–1·50) 1·16 (0·89–1·53) 1·33 (1·00–1·77)
Sickness absence due to respiratory diseases
Smoking vs non-smoking 1·41 (1·28–1·56) 1·28 (1·16–1·42) 1·29 (1·17–1·43) 1·16 (1·03–1·29) 1·52 (1·23–1·86)
High vs moderate alcohol consumption 1·08 (0·99–1·18) 1·14 (1·04–1·25) 1·15 (1·05–1·27) 0·97 (0·88–1·07) 1·53 (1·26–1·86)
Heavy episodic drinking vs no episodic drinking 1·45 (1·10–1·93) 1·45 (1·09–1·92) 1·27 (0·96–1·69) 1·23 (0·81–1·86) 1·48 (1·00–2·19)
Overweight vs normal weight 1·07 (0·99–1·16) 1·02 (0·95–1·11) 1·04 (0·96–1·13) 1·06 (0·97–1·16) 0·92 (0·78–1·10)
Obesity vs normal weight 1·56 (1·38–1·77) 1·53 (1·35–1·73) 1·45 (1·28–1·65) 1·39 (1·20–1·61) 1·47 (1·17–1·84)
Low physical activity vs moderate and high activity 1·68 (1·54–1·84) 1·42 (1·30–1·55) 1·33 (1·21–1·46) 1·38 (1·25–1·52) 1·38 (1·15–1·65)
Sickness absence due to digestive diseases
Smoking vs non-smoking 1·30 (1·09–1·54) 1·13 (0·96–1·35) 1·18 (0·99–1·41) 0·99 (0·80–1·22) 1·35 (1·01–1·82)
High vs moderate alcohol consumption 1·10 (0·94–1·30) 1·09 (0·93–1·28) 1·05 (0·89–1·24) 1·09 (0·89–1·32) 0·99 (0·74–1·32)
Heavy episodic drinking vs no episodic drinking 0·89 (0·63–1·25) 0·85 (0·60–1·19) 0·80 (0·56–1·14) 0·79 (0·49–1·28) 0·84 (0·51–1·37)
Overweight vs normal weight 1·08 (0·93–1·24) 0·99 (0·86–1·15) 1·01 (0·87–1·17)  0·99 (0·83–1·18) 0·94 (0·73–1·22)
Obesity vs normal weight 1·94 (1·56–2·42) 1·75 (1·41–2·17) 1·73 (1·38–2·17) 1·77 (1·32–2·37) 1·37 (0·98–1·92)
Low physical activity vs moderate and high activity 1·30 (1·11–1·51) 1·29 (1·11–1·50) 1·15 (0·98–1·35) 1·28 (1·06–1·54) 1·12 (0·87–1·45)
Data are rate ratio (95% CI) adjusted for each model. Sensitivity analyses (models 4 and 5) were stratified by chronic disease at baseline. Results for models adjusted for age, sex, socioeconomic status (SES), and 
chronic disease are provided in figure 1.
Table 2: Multivariable adjusted summary estimates from meta-analyses of association between lifestyle factors and diagnosis-specific sickness absence
Articles
e550 www.thelancet.com/public-health   Vol 3   November 2018
absence days due to other reasons. Sensitivity analyses, 
with the exclusion of the Whitehall and GAZEL studies, 
suggested no major differences in the results despite the 
variation in sickness absence measures (appendix, 
pp 15–16).
Discussion
Our findings, from more than 74 000 employees from the 
UK, France, and Finland, showed that lifestyle factors 
can be associated with higher diagnosis-specific sickness 
absence rates. In terms of effect size, consistency, 
robustness, and PAF for sickness absence, we determined 
a high or moderate rating for the association of high BMI 
and low physical activity with musculoskeletal diseases; 
for heavy episodic drinking, smoking, high BMI, and low 
physical activity in relation to depressive disorders; and 
for heavy episodic drinking, smoking, and high BMI in 
relation to external causes. We also determined a high or 
moderate rating for the association of smoking and 
obesity with sickness absence due to circulatory diseases 
and of smoking and low physical activity with sickness 
absence due to respiratory diseases.
Previous findings regarding the association between 
high BMI and absence due to musculoskeletal diseases 
have been inconsistent,13,15,17 but there are plausible 
mechanisms for this association, because high BMI 
might contribute to pain and limitations in mobility, 
which restrict work.27 Also, physical activity might protect 
employees from absence due to musculoskeletal 
diseases.10 These findings are plausible because physical 
activity has many beneficial effects on muscle strength 
and mobility. Although smoking provided a high 
summary estimate for musculoskeletal-related absences, 
the findings suffered from heterogeneity between 
cohorts, which has also been the case in previous smaller 
studies.13,15,17
Low physical activity, smoking, heavy episodic drinking, 
and high BMI were associated with sickness absence due 
to depressive disorders. Our findings add evidence to 
previous research and treatment guidelines, which 
suggest that targeting physical activity might reduce the 
burden associated with depressive disorders.28 Smoking is 
associated with adverse changes in brain structure and 
neural circuity in the brain regions implicated in many 
mental disorders29 and with neuroadaptations in the 
nicotinic pathways in the brain, which manifest as 
depressed mood, agitation, and anxiety shortly after a 
cigarette is smoked.30 Despite these plausible mechanisms, 
a mendelian randomisation study31 suggest ed that the link 
between smoking and depression might not be causal. 
The observed association between heavy episodic drinking 
and sickness absence due to depressive disorders is 
in accordance with previous findings on high alcohol 
consumption and mental disorder-related sickness 
absence,11 although our study was probably the first to 





External causes Circulatory diseases Respiratory diseases Digestive diseases
Smoking
Current data 17·6% 5·8 (4·1 to 7·6) 11·0 (6·9 to 15·4) 5·8 (3·4 to 8·5) 9·6 (5·0 to 14·7) 4·5 (2·7 to 6·6) 1·6 (–1·4 to 5·0)
Prevalence from external source 19·2% 6·3 (4·4 to 8·3) 11·8 (7·5 to 16·5) 6·3 (3·7 to 9·2) 10·3 (5·4 to 15·8) 4·9 (3·0 to 7·1) 1·7 (–1·6 to 5·4)
High alcohol consumption*
Current data 20·8% 0·8 (–1·0 to 2·7) 5·1 (1·4 to 9·0) 4·2 (1·5 to 6·8) –2·7 (–6·8 to 1·5) 1·9 (0·0 to 3·5) 1·6 (–1·7 to 4·9)
Prevalence from external source 30·5% 1·2 (–1·5 to 3·9) 7·2 (2·0 to 12·5) 6·0 (2·1 to 9·6) –4·1 (–10·3 to 2·2) 2·8 (0·0 to 5·0) 2·3 (–2·5 to 7·0)
Heavy episodic drinking*
Current data 8·0% 0·1 (–1·0 to 1·3) 6·7 (3·2 to 11·1) 4·9 (2·6 to 7·6) 1·7 (–1·1 to 5·4) 2·6 (0·1 to 5·7) –1·5 (–3·4 to 1·3)
Prevalence from external source 19·9% 0·2 (–2·4 to 3·1) 15·2 (7·5 to 23·7) 11·3 (6·2 to 17·0) 4·0 (–2·9 to 12·4) 6·2 (0·2 to 13·1) –3·7 (–8·9 to 3·1)
Overweight†
Current data 35·0% 8·9 (6·5 to 11·4) 2·0 (–2·8 to 6·9) 6·2 (2·6 to 9·6) 4·8 (–1·0 to 10·5) 0·3 (–2·1 to 3·2) –1·0 (–5·7 to 3·6)
Prevalence from external source 35·7% 8·9 (6·6 to 11·3) 2·0 (–2·9 to 6·9) 6·2 (2·7 to 9·6) 4·8 (–1·0 to 10·3) 0·3 (–2·1 to 3·2) –1·0 (–5·7 to 3·5)
Obesity†
Current data 11·9% 6·0 (4·6 to 7·5) 4·3 (1·3 to 7·3) 5·1 (3·0 to 7·2) 8·5 (4·6 to 12·5) 4·8 (3·0 to 6·5) 7·5 (4·1 to 10·9)
Prevalence from external source 15·9% 7·8 (6·0 to 9·7) 5·6 (1·8 to 9·4) 6·6 (4·0 to 9·3) 11·0 (6·0 to 16·0) 6·2 (3·9 to 8·4) 9·7 (5·4 to 14·0)
Low physical activity
Current data 22·4% 4·9 (3·0 to 7·1) 13·1 (8·6 to 17·7) –1·4 (–3·7 to 1·1) 5·3 (0·4 to 10·4) 7·7 (5·3 to 9·9) 5·3 (1·8 to 9·3)
Prevalence from external source 36·8% 7·8 (4·9 to 11·1) 19·8 (13·4 to 26·1) –2·3 (–6·3 to 1·8) 8·4 (0·7 to 16·1) 12·0 (8·4 to 15·3) 8·4 (2·9 to 14·5)
Data are PAF (95% CI) for sickness absence by diagnosis. Prevalence of risk factors from an external source was obtained for the general population from EUROSTAT 2014 (28 EU countries) for overweight 
(body-mass index 25–29·9 kg/m²), obesity (≥30 kg/m²), smoking (daily), and heavy episodic drinking (at least once every month); Lancet Global Health 2018 study of high-income countries for physical inactivity (not 
doing at least 150 min of moderate intensity or 75 min of vigorous intensity physical activity per week, or any equivalent combination of the two); Lancet 2018 study of 22 centres in ten European countries for high 
alcohol consumption (>100 g absolute alcohol per week; references in the appendix). *PAF for the reduction in sickness absence if people who reduced their high alcohol consumption consumed moderate levels of 
alcohol (rather than becoming abstainers); abstainers (prevalence 13·8% in current data and 15·2% in external sources) were taken into account in PAF analyses, but were not included in the reference group consisting 
of participants with moderate alcohol consumption. †Participants who were underweight (<18·5 kg/m²) were excluded from this analysis. 
Table 3: Population attributable fraction (PAF) for diagnosis-specific sickness absence adjusted for age, sex, socioeconomic status, and chronic disease
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and depressive disorders. This finding might be explained 
by at least three possible pathways: a direct causal path-
way; a so-called self-medication hypothesis (in which 
a pre-existing depressive disorder increases alcohol 
consumption); or a bi- directional or reciprocal causal 
relation ship or causation by another mechanism (such as 
genetic vulnerability).32 For high BMI and depressive 
disorders, the association might also be bi-directional.33 
However, the pathways linking obesity to depressive 
disorders have been suggested to be related to 
inflammatory factors, dysregulation of the hypothalamic-
pituitary-adrenal axis, and metabolic and psychosocial 
factors.33
Regarding sickness absence due to external causes, 
such as injuries and poisonings, our evidence 
emphasised associations with smoking, heavy episodic 
drinking, and high BMI. Smoking and heavy episodic 
drinking might reflect a risk-taking lifestyle, which 
increases the risk of accidents and injuries. Previous 
research has shown an association between smoking and 
occupational injuries.34 This link might be explained by, 
for example, smoking-induced disturbed sleep and other 
conditions that affect physical functions, which can 
increase the risk of injury. Our results are also in 
accordance with a 2017 review32 that suggested a causal 
association between high alcohol consumption and 
injuries. The risk has been shown to be directly related to 
blood alcohol concentration: the higher the concentration, 
the higher the risk.32 Other evidence suggests that 
interventions targeted at people with a drinking problem 
can reduce the risk of injuries.35 Our findings on the 
association between high BMI and sickness absence due 
to external causes add to a previous study using FPS data, 
in which the association between BMI and recorded 
occupational injuries was used as an outcome, instead of 
sickness absence.36 The underlying mechanisms might 
relate to overall fatigue, disturbed sleep, limited mobility, 
and medications for chronic diseases, which are all more 
common among people with high BMI.
We rated the evidence of smoking and high BMI in 
relation to the risk of sickness absence due to circulatory 
diseases as strong, in line with the established evidence 
on morbidity, mortality, and disability-adjusted life-
years.2,37 Our study adds to previous research by showing 
the associations with incapacity to work among working 
populations. Smoking adversely influences the circulatory 
system at all major stages of atherosclerosis, increases the 
likelihood of pathological atherothrombosis formation, 
and enhances inflammation and blood clotting.38 The 
mechanisms linking high BMI to circulatory and several 
other diseases include health behaviours, adverse 
physiological and anatomical changes, inflammation, 
and cardiovascular and metabolic dysregulation.27
We are not aware of previous studies on the association 
between low physical activity and sickness absence due to 
respiratory disease, but our findings regarding smoking 
correspond to the results from a study16 of more than 
Figure 2: Heat map of evidence of association between lifestyle factors and diagnosis-specific sickness absence
Strength of association: rate ration (RR) lower than 1·1 (low), 1·1–1·49 and significant (moderate), and 1·5 or 
higher and significant (high). Consistency: I² values greater than 50% and significant (low), 25–50% (moderate), 
and lower than 25% (high). Robustness to serial adjustments and multiple testing: RR not robust to adjustments 
(low); robust to adjustments, but not to multiple testing (moderate); and robust to adjustments and multiple 
testing (high). Population attributable fractions (PAF) on the basis of exposure prevalence estimates obtained 
from European countries (PAFexternal): greater than 10% (high), 5–10% and significant (moderate), and lower than 
5% (low). Although causal associations can be strong and weak, strong multivariable-adjusted associations are less 
likely to be confounded than weak associations. For example, an RR of 1·3 between a single confounder and 
sickness absence could explain a weak 1·05 times increase in risk of sickness absence associated with the lifestyle 
factor; the corresponding RR required to explain a strong 1·5 times increased association between the lifestyle 
factor and sickness absence would be as high as 2·4. Details of PAF calculations are provided in the appendix (p 6). 
*Overall rating is indicated as: 0 (at least one low rating in strength of association, consistency, or robustness), + 
(high or moderate rating for strength of association, consistency and robustness, and moderate PAF); or ++ (high 
or moderate rating for strength of association, consistency and robustness, and high PAF). †Data available from 
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5000 assistant nurses, whereas two other smaller-scale 
studies on the same subject12,14 reported no association. 
This positive association is as expected, given the 
hazardous load of smoking on the respiratory system. 
Physical activity, in turn, increases cardio respiratory 
fitness,28 which can protect from respiratory diseases.
To our knowledge, there are no previous studies on the 
association between obesity and sickness absence due to 
digestive diseases, but our findings are in line with 
previous evidence on obesity being a risk factor for 
digestive morbidity.39 Specific diseases that are related to 
obesity include oesophageal diseases, gastritis, diarrhoea, 
diverticular diseases, and gallbladder problems. The 
mechanisms might relate to low-grade chronic systemic 
inflammation, changes in metabolism, and the 
distribution of adipose tissue in the abdomen.39 In our 
study, neither high-volume alcohol consumption nor 
heavy episodic drinking were associated with sickness 
absences due to digestive diseases, although there is 
evidence that alcohol consumption is a risk factor for 
digestive diseases.32 This discrepancy requires future 
studies to be done with a more detailed analysis of 
alcohol consumption. 
According to our PAF results, the greatest public health 
benefits in terms of reduced sickness absence due to 
depressive disorders were related to the elimination of 
low physical activity, heavy episodic drinking, and 
smoking. Additionally, increasing physical activity would 
reduce sickness absence due to respiratory diseases, 
quitting smoking and reducing obesity would reduce 
sickness absence due to circulatory diseases, and quitting 
heavy episodic drinking would reduce sickness absence 
due to external causes. However, these findings should 
be interpreted cautiously, because the underlying 
assumption for PAF is that the observed association is 
causal and that a perfect intervention can eradicate the 
risk factor. Complete removal of lifestyle risk factors 
from the working population is unrealistic; thus, all PAF 
reported in this study are likely to be overoptimistic.
Our subgroup analyses examined lifestyle as a predictor 
of sickness absence among employees on sick leave. 
Lifestyle factors, particularly obesity, smoking, and low 
physical activity, were associated with longer or more 
frequent absences and multiple-cause absences at follow-
up. We observed fewer sickness absence days among 
participants who were overweight and had respiratory or 
digestive diseases than among those whose BMI was 
within the normal range. This difference might reflect 
weight loss associated with more severe forms of these 
diseases. Our findings on sickness absence due to 
multiple diagnoses suggest that, when treating an 
individual with sickness absence due to a specific disease, 
attention should also be paid to lifestyle factors that seem 
to increase the risk of sickness absence due to multiple 
causes. To date, there are very few intervention studies in 
this field and little evidence on the effect of lifestyle 
interventions on absence days.40,41 Another relevant topic 
for future studies involves the interactions between 
chronic diseases and lifestyle factors. Such research 
should include an analysis of disease trajectories and an 
examination of diseases that are likely to be linked to 
each other.
Common limitations in meta-analyses are heterogeneity 
between studies and small estimates that are not robust to 
adjustment for confounding. To take these limitations into 
account, we set a conservative criteria for what we defined 
as strong support: a strong association, consistency across 
studies, and robustness to adjustments and multiple 
testing. Consistency is important, because homogeneous 
study-specific estimates provide assurance that the 
association observed in a new study will be similar. By 
contrast, if the heterogeneity in study-specific estimates is 
high, unless the reasons for heterogeneity are well 
understood, the association in a new study will be hard to 
predict. For example, although the summary RRs for the 
associations between obesity and sickness absence due to 
musculoskeletal and respiratory diseases were high, they 
were not considered robust because of high heterogeneity 
in study-specific estimates. Regarding internal validity, 
bias and confounding are present to some degree in all 
observational studies. We did analyses with mutual 
adjustments for lifestyle factors to address the confounding 
that arises from the clustering of unhealthy lifestyles into 
the same individuals. We excluded participants with a 
chronic disease to reduce bias due to reverse causation 
(eg, ill health can limit physical activities) and examined 
the associations among those with chronic disease 
to assess whether the associations vary by chronic 
disease status. We used multiple-comparison corrections 
to determine statistical significance of the observed 
associations in a context of multiple testing. Our main 
analyses, adjusted for chronic diseases, represent a 
conservative approach. Chronic diseases are potential 
confounders because they affect lifestyle factors, but they 
are also on the pathway from lifestyle factors to increased 
sickness absence. We observed no major differences in the 
results regarding participants with and without chronic 
disease, which suggests that over-adjustment as a result of 
treating chronic disease as a covariate is an unlikely source 
of major bias in this study. Despite all these measures, our 
findings should be interpreted cautiously, because residual 
confounding due to unmeasured factors and bias due to 
reverse causality might have led to overestimation or 
underestimation of associations.
Further limitations to this study include self-reported 
measurements of lifestyle factors and some of the 
covariates, crude measurements of heavy episodic 
drinking and physical activity, and the fact that 
we compared current smokers with non-smokers, 
which was a heterogeneous group that included both 
ex-smokers and people who had never smoked. We did 
not assess smoking intensity, which might have yielded 
stronger associations for smokers who smoked more.42 
Because people tend to under-report their alcohol use, 
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some of the risky drinkers might have been wrongly 
assigned to the moderate drinkers group, which might 
have diluted the estimates. The study populations 
consisted of employed men and women, among whom 
the prevalence of severe alcohol use disorders is likely to 
be low, as was shown in a Finnish population-based 
study (5·2%).11
Moreover, the sickness absence data differed between 
countries. In Finland (FPS20 and HeSSup21 studies), 
diagnosis-specific sickness absence episodes are only 
registered for absences lasting longer than 9 days, 
including absences with very long duration (rehab-
ilitation and disability allowances). In the GAZEL23 and 
Whitehall II22 cohorts, sickness absence registers also 
included short-term absences. However, in GAZEL, the 
coverage of diagnoses in absences shorter than 7 days 
was about 50%.8 Shorter absences are often caused by 
respiratory diseases (common cold and other acute 
upper respiratory infections), many of which were 
missed when monitoring longer absence episodes alone. 
In FPS, HeSSup, and GAZEL cohorts, sickness absence 
data included medically certified data, whereas in the 
Whitehall II cohort, it was a mixture of records from 
self-certified absences lasting 1 to 7 days and medically-
certified absences exceeding 7 days. Further differences 
included those related to the diagnostic systems used 
(International Classification of Diseases [ICD] 10 in FPS, 
HeSSup, and GAZEL, but ICD-8 in Whitehall II). 
However, in a sensitivity analysis excluding the Whitehall 
II and GAZEL cohorts one at a time, the results remained 
largely unchanged, suggesting that variation in the data 
was not a major source of bias.
In conclusion, this multicohort study suggests that 
lifestyle-related factors are important for an individual’s 
capacity to work during an age range when the onset of 
major non-communicable diseases, permanent disability, 
and death are still very rare.2 Future studies should 
investigate the cost-effectiveness of lifestyle interventions 
aimed at reducing sickness absence and the use of 
lifestyle information for identifying groups at risk.
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